Document Detail

Early intervention for treatment and prevention of colorectal carcinomatosis: a plan for individualized care.
MedLine Citation:
PMID:  23021724     Owner:  NLM     Status:  MEDLINE    
The benefits that are reported in patients who have carcinomatosis from colorectal cancer increase as the extent of disease within the abdomen and pelvis decreases. To optimize treatments that involve cytoreductive surgery and perioperative chemotherapy, early intervention is necessary. Strategies to improve the results of carcinomatosis treatments include second-look surgery and hyperthermic intraperitoneal chemotherapy in patients at high risk for recurrence. Alternatively, the use of hyperthermic intraperitoneal chemotherapy can be used to treat or prevent carcinomatosis at the time of primary colorectal cancer resection in selected patients.
Paul H Sugarbaker
Related Documents :
23054114 - Value of tertiary cytoreductive surgery in epithelial ovarian cancer: an international ...
23154864 - Quality of life of oropharyngeal cancer patients with respect to treatment strategy and...
19861994 - Refractory neuroendocrine tumor-response to liposomal doxorubicin and capecitabine.
2472864 - Experience with the management of primary endodermal sinus tumor of the mediastinum.
24872404 - Pre-operative risk stratification for cancer-specific survival in patients with renal c...
19232434 - Cetuximab, topotecan and cisplatin for the treatment of advanced cervical cancer: a pha...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Surgical oncology clinics of North America     Volume:  21     ISSN:  1558-5042     ISO Abbreviation:  Surg. Oncol. Clin. N. Am.     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-01     Completed Date:  2013-03-05     Revised Date:  2013-04-15    
Medline Journal Info:
Nlm Unique ID:  9211789     Medline TA:  Surg Oncol Clin N Am     Country:  United States    
Other Details:
Languages:  eng     Pagination:  689-703     Citation Subset:  IM    
Copyright Information:
Copyright © 2012 Elsevier Inc. All rights reserved.
Program in Peritoneal Surface Malignancy, Washington Cancer Institute, Washington, DC 20010, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antineoplastic Agents / therapeutic use*
Carcinoma / drug therapy*,  pathology,  surgery
Chemotherapy, Cancer, Regional Perfusion / methods*
Colorectal Neoplasms / drug therapy*,  pathology,  surgery
Disease Progression
Early Medical Intervention
Hyperthermia, Induced / methods*
Individualized Medicine
Infusions, Parenteral*
Patient Care Planning
Peritoneal Neoplasms / drug therapy*,  secondary,  surgery
Second-Look Surgery / methods
Time Factors
Reg. No./Substance:
0/Antineoplastic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Randomized clinical trials for colorectal cancer peritoneal surface malignancy.
Next Document:  Do the biomechanical properties of the ankle-foot complex influence postural control for people with...